Estimation of impurity profiles of drugs and related materials: part 19: theme with variations. Identification of impurities in 3-oxosteroids
- PMID: 9919951
- DOI: 10.1016/s0731-7085(98)00206-4
Estimation of impurity profiles of drugs and related materials: part 19: theme with variations. Identification of impurities in 3-oxosteroids
Abstract
Due to the varied reactions leading to the 3-oxo group in steroids and the reactivity of its environment, a large number of impurities related to this group are formed during the reaction steps and the degradation studies. In this paper the experiences from the authors laboratory with the 3-oxo-related impurities in 19-nor-4-ene-3-oxosteroids (norgestrel, norethisterone, nandrolone, its esters and Nestorone) as well as corticosteroids (prednisolone, mazipredone, etc) are presented. The impurities include saturated 3-ones, 1-ene-3-ones, 5(10)-ene-3-ones, 3-deoxo and 3-ethinyl-3,5-diene derivatives, 6-ene, 8(14)-ene, 6,8(14)-diene, 6-hydroxy (alpha and beta), 10beta-hydroxy and 6-one derivatives in 4-ene-3-oxosteroids and 8(9)-ene, 9(11)-ene, 11alpha-hydroxy, 11-oxo and 4-ene-3-one derivatives in 11beta-hydroxy-1,4-diene-3-oxosteroids. The chromatographic, spectroscopic and hyphenated techniques used in this study include TLC, GC, HPLC with diode array UV detector, GC-MS, LC-MS and NMR methods.
Similar articles
-
Estimation of impurity profiles of drugs and related materials. Part 14: the role of HPLC/diode-array UV spectroscopy in the identification of minor components (impurities, degradation products, metabolites) in various matrices.J Pharm Biomed Anal. 1995 Dec;14(1-2):85-92. doi: 10.1016/0731-7085(95)01579-5. J Pharm Biomed Anal. 1995. PMID: 8833970
-
Estimation of impurity profiles of drugs and related materials: part XXI. HPLC/UV/MS study of the impurity profile of ethynodiol diacetate.J Pharm Biomed Anal. 2002 Aug 1;29(6):1153-7. doi: 10.1016/s0731-7085(02)00165-6. J Pharm Biomed Anal. 2002. PMID: 12110402
-
Estimation of impurity profiles of drugs and related materials Part 18. Impurities and degradation products of mazipredone.J Pharm Biomed Anal. 1998 Sep 1;17(6-7):1029-36. doi: 10.1016/s0731-7085(98)00068-5. J Pharm Biomed Anal. 1998. PMID: 9884192
-
Estimation of impurity profiles in drugs and related materials. Part 11--The role of chromatographic and spectroscopic methods in the estimation of side-reactions in drug syntheses.J Pharm Biomed Anal. 1993 Nov-Dec;11(11-12):1219-26. doi: 10.1016/0731-7085(93)80107-c. J Pharm Biomed Anal. 1993. PMID: 8123737 Review.
-
Forced degradation and impurity profiling: recent trends in analytical perspectives.J Pharm Biomed Anal. 2013 Dec;86:11-35. doi: 10.1016/j.jpba.2013.07.013. Epub 2013 Jul 31. J Pharm Biomed Anal. 2013. PMID: 23969330 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous